Nicolas Villain
@nvillain_alz
Neurologue Chercheur - Neurologist Researcher #Alzheimer #Dementia #Neurodegeneration @FaculteSanteSU @Sorbonne_Univ_ @HopPitieSalpe @APHP @InstitutCerveau
ID: 1558388311605104640
https://www.researchgate.net/profile/Nicolas-Villain-2 13-08-2022 09:42:30
2,2K Tweet
1,1K Takipçi
905 Takip Edilen
Nicolas Villain Our point of view in one slide (also with the idea of extending the concept beyond AD):
🚨The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test🚨in my accompanying Editorial Neurology Journal as supported by the excellent & necessary collaborative study led by Eduardo Zimmer Zimmer Lab et al! Special thx to Melissa Paretsky! dx.doi.org/10.1212/WNL.00…
🚨 Available as a preprint – The Alzheimer's Association #pTau round robin study 🚨 📣 33 different ways to measure #blood #pTau 📣 Mass Spec, semi & fully-auto immunoassays 📣 #pTau217 consistently best 📣 Corr. between assays = optimism for standardisation medrxiv.org/content/10.110…
I totally agree with Simon Mead. Perhaps Alberto J Espay will attend the upcoming conference secure.qgiv.com/event/mechanis… where we will discuss such issues based on scientific data. I would be curious to listen to Alberto J Espay and be allowed to challenge his incomprehensible conclusions.
Vision Impairment and the Population Attributable Fraction of Dementia in Older Adults jamanetwork.com/journals/jamao… via Jennifer Anne Deal et al Robert Howard Andrew Lees Seb Walsh Lon S. Schneider, MD Nicolas Villain Madhav Thambisetty Jason Cohen Kariem Ezzat Alberto J Espay shibley